EBD GmbH is part of the KNect365 of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring EBD Group BIO BIO-Europe Spring
Share/Follow Us
Share this:
Follow this event:

BIO-Europe Spring® Press Releases

April 18, 201610th anniversary edition of BIO-Europe Spring® 2016 hosted over 2,300 life science industry executives in Stockholm, Sweden last week The who's who in the life science industry turned out for BIO-Europe Spring® 2016 in Stockholm last week. Over 2,300 executives from 1,377 companies and 49 countries engaged in 12,452 one-to-one meetings to discuss licensing opportunities, deal potential and strategic collaborations. In addition to the one-to-one partnering, the plenary "Environment in 2016: Reverse engineerin...  more ►

April 7, 2016QureTech Bio Wins the 2016 Start-up Slam: Sweden at BIO-Europe Spring ConferenceStart-up Slam is sponsored by Karolinska Institutet Innovations and Johnson & Johnson Innovation
The winner of the Start-up Slam: Sweden, a pitching competition, taking place at BIO-Europe Spring® in Stockholm for the first time on 5 April 2016, was today announced as QureTech Bio AB, a start-up developing first line drugs to combat antibiotic resistance and infectious diseases. This special session was co-sponsored by Karolinska Institutet Innovations AB and Johnson & Jo...  more ►

March 28, 2016Invitation to a Report Launch: Stockholm Business Region to release oncology summary report at BIO-Europe Spring® 2016 During BIO-Europe Spring, Stockholm Business Region is launching the report –Oncology, world-leading research and business opportunities in the Stockholm-Uppsala Region. The report is an oncology summary including the centers of excellence, innovations, current research projects, biobanks and business opportunities in the region. Where: Level 1, Hall 1, Booth #66 When: Monday, April 4...  more ►

March 16, 2016Start-up Slam: 18 early biotechs showcased in special session at BIO-Europe Spring® 2016 Pushing its reputation for taking novel approaches, Karolinska Institutet is bringing together the best and the brightest from Sweden's early academic innovator ecosystem to present their technologies and test their skills in convincing business development executives to support their projects. Some 18 companies from across the country will come together for a competitive session called Start...  more ►

February 2, 2016BIO-Europe Spring® 2016 Event in Sweden this April will bring 2,000+ life science executives to Stockholm-Uppsala region The tenth annual BIO-Europe Spring® springtime international life science partnering conference will be held in Stockholm, Sweden, April 4–6, 2016. Organized by EBD Group, the event is co-hosted by Stockholm Business Region and Stockholm Science City Foundation. The Stockholm-Uppsala region, defined as the three counties of Uppsala, Stockholm and Sörmland, is one of ...  more ►

July 30, 2015Spotlight on Stockholm/Uppsala Region Business Facts The Stockholm-Uppsala region, defined as the three counties of Uppsala, Stockholm and Sörmland, is one of the largest life science clusters in Europe. Stockholm-Uppsala region is Scandinavia's leading life science cluster and one of the world's most productive, and is one of the most competitive business environments in Europe. On average, an astounding 15–20 new...  more ►

partnering360® Blog

April 29, 2016 Digital Health: Still a brave new world At this year’s BIO-Europe Spring® panel on “The Convergence of Therapeutics and Digital Health,” two panelists from big pharma joined two from Scandinavian digital health companies, agreeing that while the platform for digital health technologies is strong in Europe, much... more ►

April 19, 2016 The characteristics of a “winning” biotech startup QureTech Bio AB, a startup developing first line drugs to combat antibiotic resistance and infectious diseases, won the Start-up Slam: Sweden biotech competition at BIO-Europe Spring® 2016 in Stockholm, Sweden earlier this month. QureTech Bio AB participated in the pitching competition sponsored by... more ►

April 5, 2016 Images of BIO-Europe Spring® 2016 in Stockholm [See image gallery at www.partnering360.com] more ►

April 5, 2016 BIO-Europe Spring® 2016 Monday recap BIO-Europe Spring® 2016 kicked off in Stockholm, Sweden yesterday with a full program and hundreds of partnering meetings.   Morning workshops ranged from new partnerships and market access to precision medicine and vaccine development.   Mid-morning, the Stockholm Business Region... more ►

April 2, 2016 Is it possible to create new business out of clinical needs? Guest post by Björn Varnestig, CEO, Flemingsberg Science   During a period of three years, we let a group of experienced business developers (we call them business architects) walk the corridors of the Karolinska University Hospital, talking to people about the problems, needs and... more ►

partnering360:Insight Latest headlines from partnering360:Insight

April 28, 2016 PledPharma seeks partner for lead therapy Jacques Näsström, CEO of PledPharma, chats with Sten Stovall about the company’s current hunt for licensing partners for lead product PledOx (calmangafodipir). more ►

April 28, 2016 Affibody CEO describes three-year growth plan Affibody CEO David Bejker discusses the biotech's four key drug and diagnostic development programs and future plans for growing the company's portfolio of antibody mimetics. more ►

April 28, 2016 New VC bioqube on open innovation roots and investments targets Nico Vandervelpen, managing partner and co-founder of bioqube ventures, and Informa Pharma Intelligence's Mike Ward discuss the young venture capital firm's big plans for the future. more ►

April 28, 2016 QureTech Bio explains novel approach to antibiotic development CEO of QureTech Bio Dr. Fritiof Pontén explains how his company's novel class of antibacterial agents might help provide a solution to the current global crisis of antibiotic resistance. more ►

April 28, 2016 CEVEC CEO talks US deals to expand business CEVEC chief Frank Ubags speaks with Scrip's Lucie Ellis about how the platform technology company is enabling gene therapy companies to move their products into large scale clinical trials. more ►

Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD GmbH
Privacy Policy and Cookies
Terms of Use